Energy-based ablative therapy of prostate cancer: High-intensity focused ultrasound and cryoablation

Current Opinion in Urology

Volumn 17, Issue 3, 2007, Pages 194-199

  Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cryoablation; Energy based ablation; High intensity focused ultrasound; Prostate cancer

Indexed keywords

CANCER LOCALIZATION; CELL DEATH; CLINICAL PRACTICE; CLINICAL TRIAL; CRYOABLATION; ERECTILE DYSFUNCTION; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HUMAN; IMAGING; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT INDICATION; TUMOR BIOPSY;

CRYOSURGERY; HUMANS; MALE; PROSTATIC NEOPLASMS; SALVAGE THERAPY; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 34247161834     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3280dd8a65     Document Type: Review

References (43)

1. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005; 23:8146-8151.
2. Klotz L, Nam R. Active surveillance with selective delayed intervention for favourable risk prostate cancer: clinical experience and a 'number-needed to treat' analysis. Eur Urol 2006; 5 (suppl):479-486.
3. Boccon-Gibod LM, Dumoceau O, Toublang M, et al. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol 2005; 48:895-899.
4. Andren O, Fall K, Franzen L, et al. How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden. J Urol 2006; 175:1337-1340.
5. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293:2095-2101.
6. Roemeling S, Roobol MJ, Postma R, et al. Management and survival of screendetected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 2006; 50:475-482.
7. Epstein J. Pathological assessment of the surgical specimen. Urol Clin N Am 2001; 28:567-594.
8. Madersbacher S, Pedevilla M, Vingers L, et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55:3346-3351.
9. Onik G. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 2004; 3:365-370.
10. Kirkham APS, Emberton M, Clare A. How good is MRI at detecting and characterising cancer within the prostate. Eur Urol 2006; 50:1163-1175.
11. Akin O, Sala E, Moskowitz C, et al. Transition zone prostate cancers: features, detection, localization and staging at endorectal MRI imaging. Radiology 2006; 239:784-792.
12. Ter Haar GR, Robertson G. Tissue destruction with focused ultrasound in vivo. Eur Urol 1993; 23:8-14.
13. Chaussy Y, Thüroff S, Bergsdorf T. Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm®) as a treatment option [in German]. Urologe 2006; 45:1271-1275.
14. Thüroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer efficacy results from the European multicentric study. J Endourol 2003; 17:673-677.
15. Uchida T, Ohkusa H, Yamashita H, et al. Five year experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006; 13:228-233.
16. Blana A, Rogenhofer S, Ganzer R, et al. Morbidity associated with repeated transrectal high intensity focused ultrasound treatment of localized prostate cancer. W J Urol 2006; 24:585-590. This paper presents a detailed analysis of HIFU morbidity in a large single-center series.
17. Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patents. Eur Urol 2007; 51:381-387. This paper reports on a large single-center HIFU experience with a long-term follow-up.
18. Blana A, Walter B, Rogenhofer S, et al. High intensity focused ultrasound for the treatment of localized prostate cancer. Urology 2004; 63:297-300.
19. Uchida T, Ohkusa H, Nagata Y, et al. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 2006; 97:56-61. This describes a large single-institution HIFU experience with long-term follow-up.
20. Vallancien G, Prapotnich D, Cathelineau X, et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 2004; 171:2265-2267.
21. Quesson B, De Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000; 12:525-533.
22. Curiel L, Souchon R, Rouviere O, et al. Elastography for the follow-up of high intensity focused ultrasound prostate cancer treatment: initial comparison with MRI. Ultrasound Med Biol 2005; 31:1461-1468.
23. Illing RO, Leslie TA, Kennedy JE, et al. Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy. BJU Int 2006; 98:1187-1192.
24. Gelet A, Chapelon JY, Poissonnier L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high intensity focused ultrasonography. Urology 2004; 63:625-629.
25. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37:171-186.
26. Campbell SC, Krishnamurthy JK, Miller RJ, et al. Renal cryosurgery experimental evaluation of treatment parameters. Urology 1998; 52:29-34.
27. Izawa JI, Busby JE, Morgenstern N, et al. Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy. BJU Int 2006; 98:554-558.
28. Aus G. Current status of HIFU and cryotherapy in prostate cancers - a review. Eur Urol 2006; 50:927-934.
29. Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer 2006. Curr Opin Urol 2006; 16:152-156.
30. Merrick GS, Wallner K, Butler WM. Prostate cryotherapy: more questions than answers. Urology 2005; 66:9-15.
31. Spiess PE, Lee AK, Leibovivi D, et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006; 107:275-280.
32. Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003; 170:1126-1130.
33. Cytron S, Paz A, Kravchick S, et al. Active rectal wall protection using direct transperineal cryo needles for histologically proven prostate adenocarcinomas. Eur Urol 2003; 44:315-321.
34. Cresswell J, Asterling S, Chaudhary M, et al. Third generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006; 97:969-974.
35. Prepelica KL, Okeke Z, Murphy A, et al. Cryosurgical ablation of the prostate in high risk surgical outcomes. Cancer 2005; 103:1625-1630.
36. Touma NJ, Izawa JL, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005; 173:373-379.
37. Ward JF, Sebo TJ, Blute MI, Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005; 173:1156-1160.
38. Mouraviev V, Evans B, Polascik TJ. Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach. Prostate Cancer Prost Dis 2006; 9:99-101.
39. Donnelly BJ, Salikein JC, Erns DS, et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prost Dis 2005; 8:235-242.
40. Katz AE, Prepelica K, McKiernan JM, et al. Salvage cryosurgical ablation of the prostate (TCAP) for patients failing radiation efficacy and tolerability. AUA Annual Meeting Program. J Urol 2006; 175:364.
41. Lam JSLJ, Leppert JT, Koski ME, et al. Salvage cryosurgical ablation for radiocurrent prostate cancer using third generation cryoneedles: the University of California, Los Angeles experience. AUA Annual Meeting Program. J Urol 2005; 173:181.
42. Onik G, Narayan P, Vaughan D, et al. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002; 60:109-114.
43. Masson P, Prepelica KL, Lambert EH, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. AUA Annual Meeting Program. J Urol 2005; 173:179.